reason report
excel dental margin trend comment cost may
bottom line follow confer call remain posit
import take-away call quarter
view dental volum demand appear steadi
good relief follow light believ
abl show consist margin expans go
forward believ medic growth re-acceler given
rel light flu season manag kept talk
lower cost recur progress
think simpli conserv want manag
investor expect like believ end-market
stabl demand dental seem robust increas
pt maintain op
head quarter dental volum global local
intern growth dental well
growth deliv respect delight
see global local intern dental growth also like
na equip growth follow y/i declin last quarter
especi encourag y/i growth cad/cam
suggest us dentist practic continu invest
heavili busi dental equip expens
larg purchas show end-market high confid
outlook busi manag describ end-market
stabl intern dental growth also
excel view particularli encourag
growth dental consum
oper margin show expans quarter
adjust oper margin expand bp y/i view
interest like directli tie fact anim
busi spun februari sinc anim health mainli
lower margin pharmaceut product believ overal enterpris
margin show signific lift given spin stock trade
nearli intra-day share price pull back toward
afternoon suspect one reason manag said
lower oper cost experienc quarter
recur suspect tri manag investor
expect like conserv reduc
headcount close facil led lower cost
tough time see cost come back
also sinc earli year suspect want rais
expect much
compani inform svb leerink llc research
revenu billion dollar
ep adjust non-recur item restat account anim health spin
net debt total capit
price-to-earnings lt ep growth
year price history/av daili volume mil
pleas refer page import disclosur price chart analyst certif
medic growth also deliv y/i growth na
medic intern growth y/i medic growth intern
market y/i growth lower expect
believ modest slow-down like due lighter
expect flu season intern growth y/i
view fairli high creat difficult comp
segment quarter long-term would expect medic grow
high singl digit rang growth high due mainli
extra sell day two quarter due time certain
holiday europ
fx impact sever overal unfavor fx impact
sever expect total unfavor revenu
fx impact quarter headwind y/i
assum minim fx impact result slight top-lin
miss rel expect foreign currenc relat actual
underli growth busi overal much healthier
increas pt overal view quarter excel
dental volum good show solid rebound
also like bp y/i margin expans comment lower
cost like manag seek manag investor
expect like stabl medic busi appear
ep unchang though increas
pt due mainli higher convict around margin expans
inc one largest distributor medic dental veterinari suppli
office-bas practic throughout world major compani busi base
dental suppli physician offic practic distributor north america
europ australia/new zealand dental anim health market enjoy top
qualiti servic mark custom medacorp survey organ growth
rate sever compani divis modest recent reacceler make us
posit compani on-going acquisit strategi drive accret
furthermor expect multipl compress stock experienc recent
month revers investor realiz margin distant threat worri
around ftc suit wane continu solid execut quarterli result time result
sentiment shift multipl expans trough level result rate share
current trade ep premium drug
distribut pharmaci group next month
expect share trade ep would put stock
price target valuat would slightli stock
year histor averag ntm ep therefor reason view especi
given hsic consist abil grow market share deliv upsid expect
acquisit believ current multipl reflect improv sentiment
risk/reward profil improv substanti
competit relianc manufactur healthcar distribut industri north
america intern highli competit distributor compet basi price
product offer custom servic valu ad product servic competitor obtain
exclus right manufactur distribut certain product manufactur bypass
distributor altogeth could advers impact earn larg competitor
especi abroad use size increas price pressur group purchas
organ gpo larg provid may also demand lower price addit
manufactur disrupt shortag result unabl meet custom
demand certain product seen flu vaccin shortag issu
supplier relationship advers impact firm earn
acquisit restructur one largest player alternate-car market
made numer acquisit domest intern market
acquisit joint ventur involv numer risk may integr well
manag intend success integr acquisit past
immedi short-term impact bottom line drag earn year
come acquisit may result loss custom product line acquir busi
may unintend effect area oper cost increas relat
restructur integr new busi advers impact firm
earn margin
season quarterli fluctuat tradit sale higher third
fourth quarter result end year custom purchas pattern well flu
season ill quarterli earn impact number factor includ
sever flu season product avail time price chang product releas
vendor advers impact revenu firm
govern regul healthcar reform custom
healthcar industri highli regul local state feder law firm may need
adapt procedur price result polici chang govern agenc
pressur reduc budget deficit balloon healthcar cost frequent target
enact healthcar reform reduct reimburs rate public and/or
privat insur program could advers impact revenu profit margin foreign
domest tax law also subject chang current interpret subject
scrutini challeng could advers impact firm earn
ftc litig su ftc alleg price collus
believ like outcom complaint settlement possibl
complaint could expand grow crimin charg expand area
revenu
revenu
revenu
net sale
adjust incom tax
incom tax
equiti incom affili
adjust incom cont op
net incom cont op
ep continu oper
adjust ep continu oper
restat annual quarter account anim health spin
